Israeli Pharmaceuticals & Biotech Most Popular Stocks

Kamada

Market Cap: ₪1.5b

Manufactures and sells plasma-derived protein therapeutics.

Bonus BioGroup

Market Cap: ₪648.2m

A clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy.

Matricelf

Market Cap: ₪164.4m

A biotechnology company, develops a platform for autologous tissue engineering for various medical conditions.

InterCure

Market Cap: ₪163.2m

Engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.

Rekah Pharmaceutical Industry

Market Cap: ₪143.5m

Engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.

G.F.C Green Fields Capital

Market Cap: ₪140.1m

Does not have significant operations.

Seach Medical Group

Market Cap: ₪100.9m

Manufactures and sells medicinal cannabis products worldwide.

Grace Breeding

Market Cap: ₪70.4m

An agro-tech company, engages in the research and development in the area of biological substitutes for synthetic materials used in the fertilizer and growth promoter industries in Europe, the United States, South America, and Israel.

Clal Biotechnology Industries

Market Cap: ₪52.2m

A private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing.

BioLineRx

Market Cap: ₪39.2m

A commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.

Y.B Urban Renewal - Residential Development

Market Cap: ₪33.1m

Engages in real estate business.

BioLight Life Sciences

Market Cap: ₪32.5m

An ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions.

XTL Biopharmaceuticals

Market Cap: ₪29.3m

A biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel.

Evogene

Market Cap: ₪28.4m

Operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.

Nextage Therapeutics

Market Cap: ₪26.3m

A pharmaceutical company, develops cannabinoid-based products in Israel and internationally.

Purple Biotech

Market Cap: ₪22.3m

A clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.

Tikun Olam-Cannbit Pharmaceuticals

Market Cap: ₪19.4m

Engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel.

Can-Fite BioPharma

Market Cap: ₪18.0m

A clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel.

Blue Wave Water Capital

Market Cap: ₪13.4m

Engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes in Israel and internationally.

Nextgen Biomed

Market Cap: ₪7.0m

Engages in the research and development activities.

Smart Agro -

Market Cap: ₪6.1m

Focuses on the research and development in the field of agricultural technology in Israel.

HBL - Hadasit Bio-Holdings

Market Cap: ₪3.7m

Operates in the medical and biotechnology industries in Israel.